Concierge Psychiatry
of Main Line Where Your Story Matters
of Main Line Where Your Story Matters
Our Services
Outpatient, evidence-based and compassionate care for substance use disorders, including medications for addiction treatment, delivered with the privacy and continuity that recovery requires.
Substance use disorder (SUD) is a chronic, treatable medical condition—not a moral failing. According to the National Institute on Drug Abuse (NIDA), addiction changes how the brain works, which is why evidence-based treatment matters for recovery.
At Concierge Psychiatry of Main Line, Dr. Aqsa Malik, who is board-certified in Addiction Psychiatry, provides outpatient, office-based addiction psychiatry with the discretion and privacy our patients need. This includes evaluation, medication treatment for opioid and alcohol use disorders, care for co-occurring mental health conditions, and coordination with treatment programs. We understand that seeking help takes courage, and we're committed to nonjudgmental, evidence-based care.
For patients who need medically supervised withdrawal management, residential care or intensive outpatient treatment, we coordinate referral to licensed programs. A licensed CPOML treatment program is planned for the future; it is not yet available.
Prescribing of controlled medications by telehealth follows DEA rules. Current federal telemedicine flexibilities run through December 31, 2026, and some prescriptions may require an in-person visit. We also check the Pennsylvania Prescription Drug Monitoring Program as state law requires.
Withdrawal safety: Withdrawal from alcohol or benzodiazepines can be life-threatening, with risks that include seizures and delirium. Never stop suddenly without medical supervision. Severe withdrawal may need care in a hospital or another medically supervised setting. If you or someone else has a seizure, confusion, hallucinations or signs of overdose, call 911.
Medications for opioid use disorder reduce opioid use, overdose deaths and infectious disease transmission, and help people stay in treatment. The FDA has approved buprenorphine, naltrexone and methadone for opioid use disorder. Methadone for opioid use disorder is provided through licensed opioid treatment programs; we coordinate with them when it is the best option.
FDA-approved medications that reduce cravings and withdrawal symptoms and help people stay in treatment.
Integrated treatment for co-occurring mental health conditions (depression, anxiety, PTSD, bipolar disorder) that often accompany substance use disorders.
Meeting you where you are with strategies to reduce risks associated with substance use, even if you're not ready for abstinence. We provide naloxone and overdose-prevention education to every patient at risk.
Identifying triggers, developing coping strategies, and building skills to maintain long-term recovery.
Education and support for family members, who play a crucial role in the recovery process.
Research on medications for opioid use disorder:
Substance use treatment records receive additional federal privacy protection under 42 CFR Part 2, as well as protection under Pennsylvania law and HIPAA. We do not share your information without your written consent except in the limited circumstances the law allows or requires, such as medical emergencies, certain court orders, and required reporting of suspected child abuse. We explain these at your first visit.
At CPOML, we understand the importance of privacy. Our concierge model adds discretion: private scheduling and direct access to your psychiatrist.
Take the first step toward recovery. Request a private consultation with Dr. Malik.
Email is not monitored 24/7. Please do not send medical details by email. In a crisis, call or text 988, call 911, or go to the nearest emergency room.